BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Paolucci S, Piralla A, Novazzi F, Fratini A, Maserati R, Gulminetti R, Novati S, Barbarini G, Sacchi P, Silvestri A, Baldanti F. Baseline Amino Acid Substitutions in the NS5A ISDR and PKR Binding Domain of Hepatitis C and Different Fibrosis Levels and Levels of Development of Hepatocellular Carcinoma in Patients Treated with DAAs. Viruses 2020;12:E255. [PMID: 32106574 DOI: 10.3390/v12030255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Alkhatib M, Di Maio VC, De Murtas V, Polilli E, Milana M, Teti E, Fiorentino G, Calvaruso V, Barbaliscia S, Bertoli A, Scutari R, Carioti L, Cento V, Santoro MM, Orro A, Maida I, Lenci I, Sarmati L, Craxì A, Pasquazzi C, Parruti G, Babudieri S, Milanesi L, Andreoni M, Angelico M, Perno CF, Ceccherini-Silberstein F, Svicher V, Salpini R, On Behalf Of Hirma Hepatocarcinoma Innovative Research MArkers And Fondazione Vironet C Hcv Virology Italian Resistance. Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b. Viruses 2021;13:743. [PMID: 33922732 DOI: 10.3390/v13050743] [Reference Citation Analysis]
2 Cabral LKD, Grisetti L, Pratama MY, Tiribelli C, Pascut D. Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals. Cancers (Basel) 2022;14:2700. [PMID: 35681679 DOI: 10.3390/cancers14112700] [Reference Citation Analysis]